Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kathryn Romano

Chief Accounting Officer at Krystal Biotech, Inc. (KRYS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.6M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 3SEC KRYSKrystal Biotech, Inc. Sell Plan 75022,366 held (−3%) $267.60 $201K +23.9%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 2,00029,818 held (−6%) $270.56 $541K +22.6%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 5,70024,118 held (−19%) $271.66 $1.5M +22.1%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 2,82421,294 held (−12%) $272.51 $770K +21.7%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 92820,366 held (−4%) $273.71 $254K +21.2%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 55219,814 held (−3%) $274.64 $152K +20.7%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 40019,414 held (−2%) $275.68 $110K +20.3%
Feb 11SEC KRYSKrystal Biotech, Inc. Sell Plan 9619,318 held (−0%) $277.88 $27K +19.3%
  • Sell

    Chief Accounting Officer Kathryn Romano sold $201K of KRYS at $267.60 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Kathryn Romano sold $541K of KRYS at $270.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Kathryn Romano sold $1.5M of KRYS at $271.66 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Kathryn Romano sold $770K of KRYS at $272.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Kathryn Romano sold $254K of KRYS at $273.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Kathryn Romano sold $152K of KRYS at $274.64 — pre-scheduled 10b5-1 plan sale.